GEISINGER ENCOMPASS HEALTH REHABILIT — History
CCN 393047 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$17M
Latest Revenue (FY2022)
+4.6%
Revenue CAGR (3yr)
-22.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $16M | $17M | $17M | +3.7% | +4.6% |
| Operating Expenses | $19M | $20M | $21M | +3.9% | +6.1% |
| Operating Margin | -18.9% | -22.0% | -22.3% | -1.2% | +0.0% |
| Net Income | $-3M | $-4M | $-4M | -4.9% | +0.0% |
| Licensed Beds | 42 | 42 | 42 | +0.0% | +0.0% |
| Total Patient Days | 8,684 | 8,787 | 8,598 | -2.2% | -0.5% |
| Medicare Day % | 50% | 48% | 50% | +4.1% | -0.1% |
| Medicaid Day % | 1% | 1% | 1% | +8.8% | +13.0% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +9.4% ($16M → $17M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.6%
This Hospital
+7.6%
State Avg
Latest Margin
-22.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $18M | -24.0% |
| FY2024 (proj) | $19M | -25.7% |
| FY2025 (proj) | $20M | -27.4% |